AstraZeneca targets 2 billion doses, poor countries with COVID vaccine deals

The deals with epidemic response group CEPI and vaccine alliance GAVI are backed by the World Health Organisation and aim to quell concerns that the company was committing all initial supplies of the vaccine to the developed world. It is unclear if vaccines will work against the coronavirus but dozens of companies are in the race to develop one, and AstraZeneca's partnership with Oxford University is one of a handful to be backed so far by U.S. President Donald Trump's COVID task force.
Click here to read full news..